Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Nanoparticles for Diabetic Foot Ulcer
NCT07690566Completed
- Sponsor
- Deraya University
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of tadalafil in diabetic foot ulcer (DFU), sponsored by Deraya University. Primary endpoints: Number of ulcers at 6 weeks, Ulcer Size at 6 weeks and 1 more. Started Sep 2025; status: completed.
02
Drugs
tadalafil
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07690566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07690566.